跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,413 条关于
“ProNephro AKI (NGAL)”
全部
4,413
临床试验
1,754
药物
540
机构
33
资讯
2,086
去年
BioPorto Initiates US Study of ProNephro AKI (NGAL) for Adult Acute Kidney Injury Risk Stratification
去年
BioPorto Launches ProNephro AKI Diagnostic Test in US Market Through Roche Partnership
5个月前
BioPorto Divests Antibody Business for $10.5M to Focus on NGAL Biomarker Development
去年
Tailored EHR Alerts Fail to Improve AKI Management in Hospitalized Patients: KAT-AKI Trial
上个月
SeaStar Medical Reports 82% QUELIMMUNE Revenue Growth as NEUTRALIZE-AKI Trial Advances Toward Adult AKI Indication
去年
Glucarpidase Improves Kidney Recovery in Methotrexate-Associated Acute Kidney Injury
去年
SeaStar Medical Advances AKI Trial with New Site Activations and Enrollment Milestones
2年前
Arch Biopartners' LSALT Peptide Phase II Trial for Cardiac Surgery-Associated Acute Kidney Injury Approved in Turkey
去年
Arch Biopartners Advances AKI Programs: LSALT Peptide and Cilastatin Trials Progress
去年
Evotec Joins NURTuRE-AKI Consortium to Advance Multi-Omics Research for Acute Kidney Injury Treatment
第 1 页,共 209 页
上一页
下一页